Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Elanco Animal Health Incorporated

Revenue

Revenue %Chg

Revenue Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Research and Development

Research and Development %Chg

Research and Development Common Size

Marketing, Selling and Administrative

Marketing, Selling and Administrative %Chg

Marketing, Selling and Administrative Common Size

Amortization of Intangible Assets

Amortization of Intangible Assets %Chg

Amortization of Intangible Assets Common Size

Asset Impairment, Restructuring and Other Special Charges

Asset Impairment, Restructuring and Other Special Charges %Chg

Asset Impairment, Restructuring and Other Special Charges Common Size

Goodwill Impairment

Goodwill Impairment %Chg

Goodwill Impairment Common Size

Gain on Divestiture

Gain on Divestiture %Chg

Gain on Divestiture Common Size

Interest Expense, Net of Capitalized Interest

Interest Expense, Net of Capitalized Interest %Chg

Interest Expense, Net of Capitalized Interest Common Size

Other Expense, Net

Other Expense, Net %Chg

Other Expense, Net Common Size

Total Costs, Expenses and Other

Total Costs, Expenses and Other %Chg

Total Costs, Expenses and Other Common Size

Income Before Income Taxes

Income Before Income Taxes %Chg

Income Before Income Taxes Common Size

Income Tax Expense

Income Tax Expense %Chg

Income Tax Expense Common Size

Net Income

Net Income %Chg

Net Income Common Size

Basic

Basic %Chg

Basic Common Size

Diluted

Diluted %Chg

Diluted Common Size

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Depreciation & Amortization Expenses

Depreciation & Amortization Expenses %Chg

Depreciation & Amortization Expenses Common Size

Research & Development Expenses

Research & Development Expenses %Chg

Research & Development Expenses Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Non-Operating Income

Non-Operating Income %Chg

Non-Operating Income Common Size

Total Non-Operating Income

Total Non-Operating Income %Chg

Total Non-Operating Income Common Size

Income Before Provision for Income Taxes

Income Before Provision for Income Taxes %Chg

Income Before Provision for Income Taxes Common Size

Provision for Income Taxes

Provision for Income Taxes %Chg

Provision for Income Taxes Common Size

Consolidated Net Income

Consolidated Net Income %Chg

Consolidated Net Income Common Size

Net Income Attributable to Common Shareholders

Net Income Attributable to Common Shareholders %Chg

Net Income Attributable to Common Shareholders Common Size

Basic EPS

Basic EPS %Chg

Basic EPS Common Size

Diluted EPS

Diluted EPS %Chg

Diluted EPS Common Size

Basic Weighted Average Shares Outstanding

Basic Weighted Average Shares Outstanding %Chg

Basic Weighted Average Shares Outstanding Common Size

Total Shares Outstanding

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Total Revenues	4,591	4,484	4,427	4,439	4,454	4,492
Total Revenues %Chg	3.1%	-0.2%	1.4%	0.5%	2%	3.9%
Revenue
Cost of Sales	2,068	2,030	1,997	2,003	2,018	2,013
Cost of Sales
Gross Profit	2,523	2,454	2,430	2,436	2,436	2,479
Gross Profit Margin	55%	54.7%	54.9%	54.9%	54.7%	55.2%
Selling, General & Administrative Expenses	1,392	1,364	1,318	1,314	1,306	1,296
Marketing, Selling and Administrative
Depreciation & Amortization Expenses	534	527	522	527	535	542
Amortization of Intangible Assets
Research & Development Expenses	356	354	351	344	342	341
Research and Development
Operating Profit	241	209	239	251	253	300
Operating Margin	5.2%	4.7%	5.4%	5.7%	5.7%	6.7%
Interest Expense	-186	-192	-209	-235	-256	-270
Interest Expense, Net of Capitalized Interest
Non-Operating Income	-13	-4	-92	-772	-133	-124
Other Expense, Net
Gain on Divestiture
Asset Impairment, Restructuring and Other Special Charges
Goodwill Impairment
Total Non-Operating Income	-199	-196	-301	-1,007	-389	-394
Income Before Provision for Income Taxes	-16	593	536	488	412	-1,244
Income Before Income Taxes
Provision for Income Taxes	-52	159	163	150	207	11
Income Tax Expense
Consolidated Net Income	36	434	373	338	205	-1,255
Net Income
Net Income Attributable to Common Shareholders	36	434	373	338	205	-1,255
Net Income
Basic EPS	0.1	0.9	0.8	0.7	0.4	-2.6
Diluted EPS	0.1	0.9	0.7	0.7	0.4	-2.6
Basic Weighted Average Shares Outstanding	495.7	495.1	494.5	494	493.6	493.2
Total Shares Outstanding	496.8	496.6	496.5	494.4	494.3	494.2
Diluted Weighted Average Shares Outstanding	497.6	497.8	496.4	497.3	495.2	493.9
EBITDA	911	873	896	913	922	972
Effective Tax Rate	325%	26.8%	30.4%	30.7%	50.2%	-0.9%